Literature DB >> 3345117

The improving long-term outlook for patients over 70 years of age with abdominal aortic aneurysms.

E F Bernstein1, R B Dilley, H F Randolph.   

Abstract

During the past decade, selective criteria for elective surgery for abdominal aortic aneurysms have been refined based on natural history and aneurysm expansion information. Using these criteria, contemporary preoperative preparation and newer intraoperative technical adjuncts, 123 consecutive patients underwent elective resection with 1 death (mortality rate: 0.8%). These include all patients operated on with both elective and urgent aneurysms at this institution since 1978, with the exception of those with frank rupture. Most importantly, however, the 5-year life-table survival of all of these patients (average age: 71.3 years, range 46-96 yr) was 72%, including both hospital and late mortality rates. More than half of the patients were over 70 years old (78 cases), with no hospital deaths and a 5-year life-table survival probability of 67%. For those under 70 years of age at the time of operation, the 5-year life-table probability of survival was 79%. We believe that these accomplishments were a direct result of an aggressive policy of screening for and selectively treating coronary disease and carotid stenosis preoperatively and the utilization of such intraoperative adjuncts as routine Swan-Ganz monitoring, autologous blood transfusion, the cell saver, and the frequent use of the tube grafting (50%). Thus, with proper selection, the outlook for the patient over 70 years old with an elective abdominal aortic aneurysm resection now approaches that of the normal population (67% vs. 69%).

Entities:  

Mesh:

Year:  1988        PMID: 3345117      PMCID: PMC1493400          DOI: 10.1097/00000658-198803000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

2.  Routine coronary angiography prior to elective aortic reconstruction: results of selective myocardial revascularization in patients with peripheral vascular disease.

Authors:  N R Hertzer; J R Young; J R Kramer; D F Phillips; V G deWolfe; W F Ruschhaupt; E G Beven
Journal:  Arch Surg       Date:  1979-11

3.  Growth rates of small abdominal aortic aneurysms.

Authors:  E F Bernstein; R B Dilley; L E Goldberger; B B Gosink; G R Leopold
Journal:  Surgery       Date:  1976-12       Impact factor: 3.982

4.  Abdominal aortic aneurysm in high-risk patients. Outcome of selective management based on size and expansion rate.

Authors:  E F Bernstein; E L Chan
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

5.  Late survival after abdominal aortic aneurysm repair: influence of coronary artery disease.

Authors:  L H Hollier; G Plate; P C O'Brien; F J Kazmier; P Gloviczki; P C Pairolero; K J Cherry
Journal:  J Vasc Surg       Date:  1984-03       Impact factor: 4.268

6.  Abdominal aortic aneurysms: the changing natural history.

Authors:  L K Bickerstaff; L H Hollier; H J Van Peenen; L J Melton; P C Pairolero; K J Cherry
Journal:  J Vasc Surg       Date:  1984-01       Impact factor: 4.268

7.  Coronary artery disease in patients requiring abdominal aortic aneurysm repair. Selective use of a combined operation.

Authors:  S T Ruby; A D Whittemore; N P Couch; J J Collins; L Cohn; R Shemin; J A Mannick
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

8.  Is thrombosis of the infrarenal abdominal aortic aneurysm an acceptable alternative?

Authors:  R A Schwartz; W K Nichols; D Silver
Journal:  J Vasc Surg       Date:  1986-03       Impact factor: 4.268

9.  Abdominal aortic aneurysm and coronary artery disease.

Authors:  O W Brown; L H Hollier; P C Pairolero; F J Kazmier; R A McCready
Journal:  Arch Surg       Date:  1981-11

10.  Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance.

Authors:  A D Whittemore; A W Clowes; H B Hechtman; J A Mannick
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

View more
  8 in total

1.  Transabdominal inguinal hernioplasty combined with abdominal aortic aneurysm repair.

Authors:  Y Tsuji; M Yoshida; K Ataka; A Sasada; M Okada
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Periodic health examination, 1991 update: 5. Screening for abdominal aortic aneurysm. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-10-01       Impact factor: 8.262

3.  Endovascular repair of abdominal aortic aneurysms.

Authors:  W C Sternbergh; M Yoselevitz; S R Money
Journal:  Ochsner J       Date:  1999-10

Review 4.  Prognosis after graft replacement operation for abdominal aortic aneurysm.

Authors:  J Feinglass; W H Pearce; G J Martin
Journal:  West J Med       Date:  1993-10

5.  Repair of abdominal aortic aneurysm by transfemoral endovascular graft placement.

Authors:  W S Moore; C L Vescera
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

6.  The long-term survival rates of patients after repair of abdominal aortic aneurysms.

Authors:  H Moro; M Sugawara; M Shinonaga; J Hayashi; S Eguchi; M Terashima; S Kasuya; Y Yamazaki; Y Satoh; Y Maruyama
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  Long term relative survival after surgery for abdominal aortic aneurysm in western Australia: population based study.

Authors:  P E Norman; J B Semmens; M M Lawrence-Brown; C D Holman
Journal:  BMJ       Date:  1998-09-26

Review 8.  Systematic Review and Meta-analysis of Long-term survival After Elective Infrarenal Abdominal Aortic Aneurysm Repair 1969-2011: 5 Year Survival Remains Poor Despite Advances in Medical Care and Treatment Strategies.

Authors:  S S Bahia; P J E Holt; D Jackson; B O Patterson; R J Hinchliffe; M M Thompson; A Karthikesalingam
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-06-23       Impact factor: 7.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.